Recent advancement in regulatory requirements on hypertension in India as per CDSCO in comparison with south Africa

Abstract

Hypertension is a significant health issue in India and KwaZulu-Natal, South Africa, and it is associated with a considerable reduction in adverse cardiovascular disease outcomes. The India Hypertension Control Initiative (IHCI) was launched to accelerate access to treatment services and reduce hypertension prevalence by 25% by 2025. The IHCI project was designed to improve hypertension control in public sector clinics, and it was launched in the 2018–2019 in 26 districts across five states of India: Punjab, Madhya Pradesh, Kerala, Maharashtra, and Telangana. Both India and KwaZulu-Natal, South Africa, face significant public health issues related to hypertension, with 29.8% of adults suffering from the condition. India has made significant progress in addressing hypertension and refining regulatory measures. The overall occurrence of hypertension in India is 29.8%. There was a vital difference in the prevalence between urban and rural areas and among certain demographic groups in both countries. In rural areas, awareness, treatment, and control were significantly lower among men compared to women. Hypertension prevalence was higher in urban than rural areas in all studies that covered both types of area in the country. Awareness and treatment are especially important in the rural areas. It appears that hypertension is a significant issue in both countries, with higher prevalence rates in urban areas and among certain demographic groups. In this paper, we review and focus on the comparison on regulatory requirements on hypertension in both the countries.